Researches in the last decades have demonstrated that inflammation plays an essential role in the pathogenesis and progression of atherosclerosis.
15 min, then a gradient to 30A/70B for 35 min, and further for 5 min to 100B. An Alltech Evaporative Light Scattering Detector (ELSD) 2000 (tube temperature: 108.9°C; gas flow rate: 2.9 ml/min) was employed for the detection.
Drugs and Reagents PSF solutions were prepared by dissolving the fraction product in 30% 1,2-propanediol solution for intraperitoneally administration, or in 0.5% (w/v) carboxymethylcellulose sodium salt (CMC-Na) for oral administration. Indomethacin, carrageenan, histamine, 1,2-propanediol and Tween-80 were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Acetic acid (AR grade) was a Uni-Chem reagent. Rotundine was purchased from Guangzhou Shiqiao Pharmaceutical Co., Ltd., Guangzhou, China.
Animals Male ICR mice of 18-24 g and male SD rats weighing 150-210 g were purchased from the Laboratory Animal Services Center, Chinese University of Hong Kong, Hong Kong. All animals were acclimated for Ն1 week under 12 h light and 12 h dark cycle at room temperature of 22Ϯ1°C. Chow diet and water were provided ad libitum. Animal care and treatment procedures conformed to the Institutional Guidelines and Animal Ordinance Hong Kong Special Administrative Region. Mice and rats were fasted for 16 h and 48 h, respectively, before experiment.
Induction of Acute Inflammation in Rat Hind Paws by Histamine Acute inflammation in the hind paws was induced by the subcutaneous injection of 0.05 ml of the prepared solutions of histamine (1%) into the right hind paws of the rats. The left hind paws without injection were used as control. The volumes (ml) of both hind paws of rat were measured using a plethysmometer (Plethysmometer 7150, UGO Basile, Italy) at 1 h before induction and 0.5, 1, 2, 3, 4, 6 h after induction of the inflammation. The increased volumes (paw edema) of the right hind paws of rats were calculated by the following equation: the increased rate (%)ϭ (BϪA)/Aϫ100, where A and B represent the paw volumes before induction of inflammation and at different time points after the induction, respectively. PSF (100, 50, 25, 12.5 mg/kg) or vehicle were intraperitoneally administrated 10 min prior to histamine injection. The reference drug, indomethacin (10 mg/kg), was orally administered 1 h prior to histamine injection.
Visceral Nociceptive Model Induced by Acetic Acid Stimulation in Mice
The abdominal writhing test induced by acetic acid stimulation in mice as originally described by Siegmund et al. 15) Briefly, PSF (200, 100, 50 mg/kg) or vehicle (0.5% CMC-Na) were orally administrated 0.5 h prior to acetic acid injection. The reference drug rotundine (50 mg/kg), an analgesic drug derived from the tuber of Corydalis yanhusuo W. T. WANG in China, was orally administrated 2 h before acetic acid injection. Immediately after intraperitoneal injection of 0.2 ml acetic acid (0.8% w/v) in physiological saline (0.9% w/v NaCl), animals were isolated for observation. The numbers of abdominal writhing episodes, which consisted of contraction of the abdominal area with extension of hind legs, were recorded during a 15 min period after injection of acetic acid in each animal.
Central Nociceptive Model Induced by Radiant Heat Stimulation in Mice
The antinociceptive effect of PSF and the reference drug, represented by the time required for mice tail flick after exposure to a source of radiant heat, were evaluated according to the description of D'Amour and Smith. 16) Briefly, each animal was placed in a plexiglas box that allowed its tail to be free, then the box was placed on the tail stimulator analgesia meter (IITC Inc., U.S.A.) with the tail occluding a slit over a photocell for radiant heat stimulation generated by a power lamp mounted in a reflector. The tailflick response was elicited by applying radiant heat to the point 1/3 of length away from the tip of the tail. When the mouse felt pain and flicked its tail, the light of the lamp fell on the photocell such that the timer was automatically stopped. The intensity of the heat stimulus in the tail-flick test was adjusted so that the mouse flicked its tail within 3 to 6 s. A 12 s cut-off time was set in order to prevent tail tissues from being damaged. Before experiment, the heat stimulation latency of all animals were tested, and those with response time of Ͻ2 or Ͼ6 s to heat stimulation were excluded. The tail-flick responses were measured at 0.5, 1, 2, and 3 h after oral administration of PSF (200, 100, 50 mg/kg), vehicle (0.5% CMC-Na), or rotundine (50 mg/kg).
Western Blot Analysis for Determination of COX-1 and COX-2 Protein Expressions COX-1 and COX-2 protein expressions were investigated in carrageenan induced paw edema model in rats. The edema was induced according to Winter's method. 17) In brief, each rat was injected with 0.1 ml of freshly prepared carrageenan (1% w/v) in physiological saline (0.9% w/v NaCl) into the subplantar tissues of the right hind paw. PSF (100, 50, 25, 12.5 mg/kg) or vehicle were intraperitoneally administrated 10 min in advance. The reference drug, indomethacin (10 mg/kg), was orally administered 1 h prior to carrageenan injection. At 4 h after injection of carrageenan, the edema paw tissues from PSF, indomethacin, or vehicle treated animals were collected for COX-1 and COX-2 determination. The collected soft tissues were homogenized in RIPA buffer containing 1 mM phenylmethylsulphonyl fluoride (PMSF), 10 mg/ml aprotinin, 1 mM pepstatin and 10 mM leupeptin. The homogenates were centrifuged at 12000 g for 20 min, and then 50 mg of protein from the supernatants was separated on 8% sodium dodecylsulphate-polyacrylamide gel and transferred to polyvinylidene difluoride membranes (Milipore, MA, U.S.A). Following the transferring, the membranes were blocked overnight at 4°C with 5% skim milk in Tris-buffered saline (TBS, 20 mM Tris, 500 mM NaCl, pH 7.5). The membranes were then incubated with rabbit polyclonal anti-COX-2 (3 mg/ml, Vision, Fremont CA, U.S.A), mice monoclonal anti-COX-1 (5 mg/ml, Cayman Ann Arbor, MI, U.S.A.) for 1 h at room temperature. The membranes were washed six times with Tris-buffered saline-Tween (TBST, 20 mM Tris, 500 mM NaCl, pH 7.5, 0.14% Tween 20) . The membranes were then incubated with 1:10000 dilution anti-rabbit (Zymed, South San Francisco, CA, U.S.A.) or anti-mouse IgG secondary antibody (Zymed, South San Francisco, CA, U.S.A.), and then conjugated to horseradish peroxidase in 2% skim milk in TBST for 1 h at room temperature. The membranes were washed six times, and the immunoreactive proteins were detected by enhanced chemiluminescence (ECL) using hyperfilm and ECL reagent (Amersham International plc., Buckinghamshire, U.K.). The relative optical density of bands was quantified by densitometric scanning of the Western blots.
Bio-Plex Assay for Cytokines Determination of IL-1b b, IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN-g g, TNF-a a in Rat Paw Tissues To obtain paw exudates, rats were killed by Et 2 O at 4 h after intraplantar carrageenan injection. Each hind paw was amputated at the level of the calcaneus bone and a cross incision was made in the surface of paws, and then centrifuged at 400 g for 15 min at 4°C to collect the exudates (edema fluid). The levels of interleukin (IL)-1b, IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN-g and TNF-a in paw exudates at 4 h after carrageenan injection were measured by using Bio-Plex rat cytokine assay. Briefly, the premixed standards were reconstituted in 0.5 ml of culture medium, generating a stock concentration of 50000 pg/ml for each cytokine. The standard stock was serially diluted in the same culture medium to generate 8 points for the standard curve. The assay was then performed in a 96-well filtration plate supplied with the assay kit. Premixed beads (50 ml) coated with target capture antibodies were transferred to each well of the filter plate and washed twice with Bio-Plex wash buffer. Premixed standards or samples (50 ml each) were added to each well containing washed bead. The plate was shaken for 30 s and then incubated at room temperature for 30 min with lowspeed shaking. After incubation and washing, premixed detection antibodies (50 ml) were added to each well. The incubation was terminated after shaking for 10 min at room temperature. After washing three times, the beads were resuspended in 125 ml of Bio-Plex assay buffer and then were read on the Bio-Plex suspension array system. Data were analyzed using Bio-Plex Manager software with 5PL curve fitting.
Statistical Analysis Values of the data were expressed as the meansϮS.E.M. Statistical significance of the differences was assessed by ANOVA and, if significance found, by multiple comparison with SNK method. p Values less than 0.05 were considered statistically significant. Figure 1 shows the chemical profiles of PSF characterized by HPLC fingerprints with twenty peaks detected. Peaks 2 (10.23%), 9 (6.45%), 10 (12.27%), 12 (27.47%), 13 (8.76%) and 15 (5.09%) considered as the characteristic and representative saponin constituents in the fraction were identified as ilexsaponin B 3 , pubescenoside C, ilexsaponin B 2 , chikusetsusaponin IVa, ilexsaponin A 1 , and ilexsaponin B 1 , respectively, by comparing the retention time of the peaks with the relevant standard chemical substances. Those six identified compounds accounted for 70.27% of the total peak area of PSF with twenty peaks in the HPLC chromatographic analysis ( Fig. 1) .
RESULTS

Chemical Profiles of PSF Characterized by HPLC Chromatographic Fingerprints and Identification of the Representative Single Saponin Compounds in PSF
Inhibitory Effect of PSF on Histamine-Induced Paw Edema of Rats In histamine-induced rat paw edema, measurements were conducted at 0.5, 1, 2, 3, 4 and 6 h after subcutaneous injection of histamine. As shown in Fig. 2 , the hind paw edema of rats peaked at 0.5 h and then rapidly decreased from 1 h onward after the injection. The left hind paws that were used as control showed no increase of paw Vehicle (30% propanediol) treated rats served as control group. PSF and the vehicle were i.p. injected 10 min prior to the induction. Reference drug was orally administeredvolume during the entire experiment (data not shown), suggesting that the right hind paw edema was successfully induced by intraplantar injection of histamine. Administration of PSF by i.p. injection with dosages of 100, 50, 25 and 12.5 mg/kg showed significant inhibition of the edema at 0.5, 1 and 2 h after the injection; This inhibitory effect could last for 4 h in the animals treated with PSF at 100, 50 and 25 mg/kg. These results suggested that the anti-inflammatory effect of PSF was time-dependent. In the early stage (0.5 to 1 h after histamine injection), PSF showed strong and dosedependent inhibition on the paw edema with dosages of 25 to 100 mg/kg. However, in the late phase (2 h after histamine injection), PSF affect the paw edema to a less intensity without dose-dependence. Indomethacin showed also significant inhibition of paw edema for at least 4 h after histamine injection.
Analgesic Effect of PSF in Nociceptive Models of Mice
The abdominal writhing assay of writing induced by peritoneal injection of acetic acid and tail flicking evoked by radiant heat stimulation in mice were employed in the study. Figure 3 shows the numbers of abdominal writhing episodes evoked by i.p. injection of acetic acid in the PSF-treated and control animals. It can be seen that treatment with PSF at doses of 200 and 100 mg/kg could significantly reduce the number of writhing episodes of mice in comparison with that of the vehicle-treated animals. The reference drug rotundine which has been known to exert its analgesic activity by blocking dopamine receptor produced potent analgesic effect at dosage of 50 mg/kg. 18) In Fig. 4 , it can be seen that the tail flick reaction time of animals in the control group held constant at around 5 s for 0.5, 1 and 2 h after dosing with the vehicle; in contrast, treatment with PSF at a dosage of 200 mg/kg or with the reference drug rotundine at 50 mg/kg significantly prolonged tail flick reaction time at 0.5, 1 and 2 h after drug administration. In addition, an almost identical potency of analgesia was obtained in the animals treated with PSF at a dosage of 200 mg/kg or with rotundine at a dosage of 50 mg/kg. Administration of PSF with dosages of 100 mg/kg only showed significance at 1 h after administration, and 50 mg/kg showed only mild degrees of analgesia. These results suggested that PSF could exert the strongest analgesic effect at 1 h after oral administration, and at this time point, it showed in a dosedependent manner.
Inhibition of COX-2 Protein Expression in Rat Paw
Tissues Induced by PSF At 4 h after the induction of paw edema caused by intraplantar injection of carrageenan, protein expressions of both COX-1 and COX-2 enzymes in edema hind paw tissues of rats were examined. In Fig. 5 , significant protein expressions of COX-1 and COX-2 can be
Fig. 6. Influence of PSF on the Production of IL-1b (A), IL-6 (B), TNF-a (C), IL-2 (D), GM-CSF (E), IFN-g (F), IL-4 (G) and IL-10 (H) in Intraplantar
Carrageenan-Injected Paw Tissues of Rats PSF (100, 50, 25 mg/kg, i.p.) was administrated 10 min before carrageenan injection. At 4 h after the injection, the paws exudates were collected for cytokines measurement using Bio-Plex rat cytokine assay. The vehicle (30% propanediol, i.p.) treated rats served as the control group. Each column represents the meanϮS.E.M. (nϭ6-9). * pϽ0.05, * * pϽ0.01, * * * pϽ0.001, compared with the control group.
seen in the paw tissues of control animals. In the paw tissues of treated animals, PSF at all tested doses showed no inhibition on COX-1 protein expression, while the reference drug indomethacin demonstrated some degree of inhibition (the left side of Fig. 5 ). However, with regard to COX-2 protein expression, treatment with PSF at dosages of 12.5 to 100 mg/kg demonstrated significant suppression, as the positive drug indomethacin did (the right side of Fig. 5 ). These indicate that PSF possesses a selective inhibitory potency on COX-2 protein expression but not on COX-1, which is probably different from the mode of drug action produced by indomethacin.
Effects of PSF on Levels of IL-1b b, IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN-g g and TNF-a a in Paw Tissues of Rats
Levels of IL-1b, IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN-g and TNF-a in the paw tissues of rats collected at 4 h after intraplantar injection of carrageenan were determined by using Bio-Plex assay, a recently developed suspension bead array technology that allows simultaneous measurement of multiple cytokine targets from a single sample in a microplate well. As shown in Fig. 6 , IL-1b, IL-6 and TNF-a were detected with higher levels than that of other cytokines in the hind paw exudates of rats. Intraperitoneally pretreatment of PSF 10 min prior to carrageenan injection could reduce the levels of IL-1b and IL-6 and TNF-a (Figs. 6A-C) . The reference drug indomethacin could also attenuate the levels of IL-1b, IL-6. On the production of IL-2 (Fig. 6D) , GM-CSF (Fig. 6E) and IFN-g (Fig. 6F ), PSF appears to exhibit a biphasic effects. At high dosage (100 mg/kg), PSF treatment seems to promote the production of these cytokines (without significance), while at the low dosage (25 mg/kg), PSF attenuated the production of these cytokines, especially reduced the production of IL-2 and GM-CSF significantly. In addition, the levels of anti-inflammatory cytokines of IL-4 and IL-10 (Figs. 6G, H) were markedly increased in the paw tissues of PSF-treated animals at the dosage of 100 mg/kg in comparison with those levels in the vehicle-treated animals. However, PSF reduced the production of IL-4 significantly at dosage of 25 mg/kg, indicating a biphasic effect on IL-4 formation. The reference drug indomethacin significantly decreased the production of these two cytokines (Figs. 6G, H) , resulting in markedly lower concentrations of IL-4 and IL-10 in the paw tissues of experimental animals as compared with control animals. These findings indicate that the mode of drug action and effective mechanisms of PSF is in some ways different from that of indomethacin, although both of them demonstrated potent anti-inflammatory activity in rats.
DISCUSSION
In recent decades, traditional herbal medicines have been becoming more and more popular in the world, both for maintaining health and treating chronic complicated or refractory diseases as a complementary or alternative to conventional western medicine. Efficacies of those traditional treatments have been obtained in many cases including chronic inflammatory and arthritic illnesses. In the current work, the saponin fraction of MDQ, a commonly used herb in Chinese medicine, was investigated for its anti-inflammatory and analgesic properties based on the long historical usage in clinic and our previous investigation. The results of the study showed that PSF significantly suppressed the hind paw edema of rats induced by intraplantar injection of histamine, indicating marked anti-acute inflammatory potency.
In our previous investigation, PSF has been demonstrated to have anti-inflammatory effect at the dosages of 12.5 to 100 mg/kg on the carrageenan-induced paw edema in rats. 14) In the current study, the anti-inflammatory effect of PSF was further evaluated in the histamine-induced paw edema in rats. Histamine is a potent mediator to act in acute inflammation; it is produced in the early phase of acute inflammation to increase vascular permeability. Since the action of histamine is transient, the inflammation decreases very quickly after induction. Hence the early inflammatory response appears to be mediated mainly by histamine. In our study, PSF showed strong and dose-dependent inhibition on the paw edema in the early phase of the inflammation, implying that PSF exert the anti-inflammatory effect by acting on the early phase of the inflammation. In the late phase, PSF showed a weak anti-inflammatory effect which didn't show dose-dependency, this might be due to the decrease in activity of PSF which might result from the elimination of PSF, as well as the possible synergistic or offsetting effects between individual components in PSF, which induced different patterns of the overall effect of PSF at different dosages.
In addition, PSF exhibited potent analgesic effect in nociceptive models of mice. Mechanistic studies have shown that PSF treatment could selectively suppress COX-2 protein expression, decrease the levels of multiple proinflammatory cytokines, especially the levels of IL-1b, IL-6 and TNF-a, and increase the levels of anti-inflammatory cytokines of IL-4 and IL-10 in the hind edema paw tissues of rats evoked by intraplantar injection of carrageenan, in comparison with that of the vehicle-treated animals.
Inhibition of the protein expression of cyclooxygenases has been widely accepted as one of the important molecular targets of anti-inflammatory agents. Classic anti-inflammatory agents, non-steroidal anti-inflammatory drugs (NSAIDs), are used worldwide as anti-inflammatory, antipyretic and analgesic remedies through the inhibition of COX enzymes activities. 19, 20) Since the early 1990s, it has been known that two COX enzymes, COX-1 and COX-2, are responsible for the production of prostaglandin (PG) H 2 , the first step in prostanoids biosynthesis. COX-1 is responsible for the physiological production of prostanoids while COX-2 induces the elevated production of prostanoids that occurs at the sites of disease and inflammation. 21) Clinically, although commercially available NSAIDs are often prescribed as antiinflammatory agents, serious adverse side effects significantly limit their usage. A hypothesis has been accordingly suggested to explain the effects of NSAIDs that inhibition of COX-1 accounts for the side effects while inhibition of COX-2 accounts for the therapeutic benefits of NSAIDs. 22) Thus, selective inhibition of the COX-2 enzyme appears to be the desirable target for anti-inflammatory/analgesic agents with improved gastrointestinal tolerability. In the past two decades, several COX-2 selective inhibitors such as Celecoxib, Valdecoxib, Parecoxib Sodium, Rofecoxib, Etoricoxib and Lumiracoxib have been developed. 23) Inhibition of COX-2 protein expression has also become the most popular target for screening anti-inflammatory agents as well as for the study of pathogenesis and pathology of the inflammatory and nociceptive processes in animal models. 24) In the current study, it was showed that PSF at dosages of 12.5 to 100 mg/kg could significantly suppress the protein expression of COX-2 but not COX-1 in the edema paw tissues of rats, while indomethacin could inhibit both COX-1 and COX-2 expression significantly. These results suggest that the PSF of MDQ could play a role in anti-inflammation in the model of carrageenan-induced paw edema of rats through inhibition of COX-2 protein expression at the sites of inflammation.
As cytokines are critical to the pathogenesis of inflammatory disorders, inhibition of their production and action provides therapeutic benefits in various inflammatory and arthritic diseases. Injection of the inflammatory agent, carrageenan, in the rat hind paws is a model frequently employed to study acute inflammation and evaluate the antiinflammatory activity of various candidate compounds and agents. Previous studies have shown significant correlations among cytokines production, COX-2 protein expression and prostaglandins synthesis in the paw tissues of rats in which edema was invoked by intraplantar injection of carrageenan. 24, 25) In the current study, besides significant inhibition of COX-2 protein expression by pretreatment of PSF, the production of multiple proinflammatory cytokines including IL-1b, IL-6, and TNF-a in hind paw tissues of rats was also decreased by PSF treatment. Thus, inhibition of the proinflammatory cytokines production is believed to be one of the pathways by which PSF exerts its anti-inflammatory effect in this model.
In contrast to the proinflammatory cytokines, some 'antagonist cytokines', such as IL-10, IL-4 and IFN-g, have been reported to inhibit the production of proinflammatory cytokines. 26, 27) IL-10 could inhibit the production of IL-2, IL1b, TNF-a, GM-CSF.
27) It can also induce the formation of IL-1 receptor antagonist, another anti-inflammatory cytokine. 28) Injection of a monoclonal antibody to mouse IL-10 can potentiate carrageenan-and TNF-a-evoked inflammatory pain. 29) These results, taken together, suggest that the administration of IL-10 may have therapeutic potential in acute and chronic inflammatory diseases. In addition to IL-10, another inhibitory cytokine, IL-4 is known to limit production of the proinflammatory cytokines, IL-1b, IL-6, IL-8 and TNF-a. 30 ) Also, IL-4 can suppress delayed-type hypersensitivity responses in experimental animals and in man. 31) Moreover, both IL-4 and IL-10 have been reported to inhibit the induction of COX-2, with a consequent reduction in the production of prostaglandins. 32, 33) Our current study showed that PSF at a relatively high dosage could significantly increase the production of anti-inflammatory cytokines of IL-10 and IL-4 in the paw tissues of rats, which is believed to be beneficial to the amelioration of the paw edema of animals. In contrast, indomethacin could not augment but, rather, significantly inhibit the production of IL-4 and IL-10. These results demonstrate the differences in drug properties between indomethacin and PSF of MDQ. Moreover, both PSF and indomethacin demonstrated inhibitory but not stimulatory effect to the production of IFN-g in the paw tissues of rats.
Besides the inhibitory effect on several proinflammatory cytokines and enhancing effect on anti-inflammatory cytokines production, PSF also showed a kind of biphasic effect on the production of IL-2, GM-CSF, IFN-g and IL-4. This biphasic effect might be due to complex constituents of PSF which might interact with each other to yield synergistic or offsetting interactions.
In addition, like the positive agent rotundine, PSF demonstrated potent analgesic effect both in the visceral and central nociceptive mouse models induced by i.p. injection of acetic acid and by radiant heat stimulation, respectively. Although the analgesic mechanisms of PSF were not investigated in the current study, previous studies showed that acute inflammatory pain is usually characterized by hypernociception due to the sensitization of primary sensory nociceptive neurons, also referred to as hyperanalgesia or allodynia; while eicosanoids and sympathetic amines are the most important primary mediators ultimately responsible for the mechanical hypernociception in rodents. Moreover, even though the release of primary hypernociceptive mediators is not directly stimulated by inflammatory stimuli, it is preceded by the release of a cascade of proinflammatory cytokines. 34) Therefore, there might be underlying correlations between the antiinflammatory and analgesic actions of PSF.
Regarding chemical constituents of PSF, HPLC chromatograghic analysis showed that it is a saponin fraction with twenty peaks in the chromatogram, from which six saponins have been identified, including two novel saponins obtained. Previous studies showed that saponins are the major chemical ingredients in medicinal herbs responsible for most of the observed biological activities. 35, 36) Recent reports further indicated that most saponins can suppress the expression of COX-2 and iNOS, thus resulting in a marked lowering of levels of prostaglandin E 2 (PGE 2 ). 37) Moreover, the soybean saponins were reported to significantly inhibit the release of TNF-a 38) while platycodon D (PD) and PD3 increase the secretion of TNF-a as well as expression of TNF-a mRNA from RAW 264.7 cells in vitro. 21) Taken together, the saponin fraction of MDQ is believed to be valuable of further investigation.
In conclusion, the present study demonstrated that PSF exhibits potent suppressive effect on histamine-induced acute paw edema in rats. The molecular mechanisms are considered to be closely related to the inhibition of COX-2 protein expression, proinflammatory cytokines production, and especially decreasing levels of IL-1b, IL-6, and TNF-a in the paw tissues of the PSF-treated animals. In addition, PSF can significantly elevate the tissue levels of anti-inflammatory cytokines of IL-4 and IL-10, which helps relieving inflammation. Besides, PSF also showed significant analgesic effect in both visceral and central nociceptive models. Although there might be some correlations and common molecular pathways, such as inhibition of proinflammatory cytokines production, between the effects of anti-inflammation and analgesia of PSF, the exact mechanisms by which PSF exerts its analgesic effect need to be further investigated.
